The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats
- DOI
- 10.1016/j.neuropharm.2024.110257
- Published
- 2025-03
- Container
- Neuropharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.neuropharm.2024.110257,
title = {The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats},
author = {Kelsey G. Guenther and Jonah L. Wirt and Idaira Oliva and Shahin A. Saberi and Jonathon D. Crystal and Andrea G. Hohmann},
year = {2025},
journal = {Neuropharmacology},
doi = {10.1016/j.neuropharm.2024.110257},
url = {https://doi.org/10.1016/j.neuropharm.2024.110257}
}RIS
TY - JOUR TI - The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats AU - Kelsey G. Guenther AU - Jonah L. Wirt AU - Idaira Oliva AU - Shahin A. Saberi AU - Jonathon D. Crystal AU - Andrea G. Hohmann PY - 2025 JO - Neuropharmacology DO - 10.1016/j.neuropharm.2024.110257 UR - https://doi.org/10.1016/j.neuropharm.2024.110257 ER -
APA
Guenther, K. G., Wirt, J. L., Oliva, I., Saberi, S. A., Crystal, J. D., & Hohmann, A. G. (2025). The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2024.110257
Source records
- crossref · retrieved 2026-09-27T00:42:11.903Z